The liquid pharmaceutical composition according to any of the previous embodiments, wherein said composition has a mild or very mild pain intensity upon administration by injection to a patient
Eating disorder risk For individuals with a history of disordered eating, GLP-1-induced appetite suppression can unintentionally reinforce restriction or trigger old patterns
3 Work with your prescriber on prior authorization If your BMI is 40 or higher, your prescriber will document it and submit a PA with clinical supporting materials including comorbidities, participation in a weight-management program, and any renewal-specific weight-loss progress
10.1095/biolreprod61.3.635 6 BaiJ.WangX.ChenY.YuanQ.YangZ.MiY.et al (2024)
If side effects persist beyond 8 weeks at your current dose, your PlexusDx provider can adjust timing or explore alternatives
Cardiovascular benefits also diminish